Mediterranean-diet results favor metabolic measurements, with very low certainty
In patients with metabolic syndrome, Mediterranean-diet approaches showed better body-size and metabolic measurements than other diets or treatments. The review rated the evidence as very low certainty.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The pooled results favored Mediterranean-diet approaches for measures such as body size, blood glucose, blood fats and insulin resistance, meaning reduced responsiveness to insulin. These are intermediate measurements, not evidence here of fewer heart attacks or diabetes cases. The authors rated the evidence as very low certainty, so the apparent improvements require cautious interpretation.
Studies differed enough to limit generalization. The abstract does not specify the units for its reported effect estimates or provide follow-up durations, preventing a clear account of their size and persistence.
What the review measured
Reported outcomes included waist size, blood glucose, triglycerides, a type of blood fat, and measures of insulin resistance. The abstract lists favorable average differences but does not specify their measurement units.
Why favorable results remain uncertain
Statistically significant results and confidence in the evidence answer different questions. Here, the authors reported favorable comparisons while judging the overall evidence very uncertain; the statistical findings do not remove that qualification.
The original publication
Comparison of the Mediterranean Diet and Other Therapeutic Strategies in Metabolic Syndrome: A Systematic Review and Meta-Analysis.
Bruna-Mejias A, San Martin J, Arciniegas-Diaz D et al.
Int J Mol Sci · 2025
- PubMed ID
- 40565352
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.